                </a></li></ul></div><p><strong>Figure 3.  <span>Characterization of morphine and M6G in SH-SY5Y extracts.</span></strong></p><a id="article1.body1.sec2.sec3.fig1.caption1.p1" name="article1.body1.sec2.sec3.fig1.caption1.p1"></a><p><em>A.</em> Purification of morphine and M6G. Upper panel, RP-HPLC chromatogram showing the purification of endogenous alkaloids from SH-SY5Y cells (375Ã—10<sup>6</sup> cells). Lower panel, RP-HPLC purification of morphine (Mor) and M6G standards (500 pmol). <em>B.</em> Characterization of M6G. Q-TOF MS-MS analysis of the HPLC fraction showing M6G in the intragranular material (marked with an arrow in <a href="#pone-0001641-g003">Fig. 3A</a>, upper panel). The fragment at 462.12 Da corresponds to M6G, whereas the 286.18 Da fragment corresponds to morphine. <em>C.</em> Q-TOF MS analysis of the HPLC fraction showing morphine (286.17 Da) in the intragranular material (marked with an arrow in <a href="#pone-0001641-g003">Fig. 3A</a>, upper panel).</p>
